medigraphic.com
ISSN 1025-0255 (Electronic)

2017, Number 4

<< Back Next >>

AMC 2017; 21 (4)

Malignant incidence of osseous tumors in children: a five-year study

Rodríguez REI, Fernández GG

Language: Spanish
References: 20
Page: 510-517
PDF size: 507.91 Kb.


ABSTRACT

Background: malignant bone tumors in children are quite rare. When compared to the rest of the childhood tumors it occupies only 3 to 4%. Despite their low frequency, they are important because of their high mortality, ranging from 80 to 95%, and the serious physical and emotional sequelae that their treatment entails in patients. The most frequent types of malignant bone tumor at that age are Ewing's sarcoma and osteogenic sarcoma. Objective: to determine the most frequent malignant bone tumors with a five-year study of the cases admitted to the Eduardo Agramonte Piña University Pediatric Hospital in Camagüey under the age of 19 years. Methods: an observational, descriptive, longitudinal and retrospective study was carried out through a review of the anatomy pathology file of the Eduardo Agramonte Piña University Pediatric Hospital in Camagüey. We studied all cases with histopathological diagnosis of malignant bone tumor from January 1, 2012 to December 31, 2016, with ages below 19 years. The source of information was the biopsy record book of the Department of Pathology. The data obtained were compiled in a form prepared for them. Statistical analysis was performed using the standard professional package S.P.S.S version 21 2012. The results were presented in tables. Results: Ewing’s sarcoma and osteogenic sarcoma were the most frequent malignant tumors. The most frequent age group of bone tumors was between 10 and 14 years. Conclusions: the results of the study are comparable to those reported in the medical literature where malignant bone tumors, Ewing's sarcoma and osteogenic sarcoma are the most common.


REFERENCES

  1. Gustavo Mora Ríos F, Bustamante Torres BB, Carlos Mejía Rehenes L, Díaz Zavala FA, López Marmolejo A, Beltrán Ortega C, et al. Frecuencia de tumores óseos benignos en niños. Rev Esp Méd Quir. Jul-Sep 2012;17(3):179-85.

  2. Tachdjian MO. The Foot and Leg. En: Tachdjian MO, editor. Pediatric Orthopaedics. 4 ed. España: Elseiver; 2008. p. 1240-1520.

  3. Romeo Tecualt Gómez R, Moreno Hoyos LF, Alonso Amaya R. Clasificación de los tumores óseos. Ortho-tips. Abr-Jun 2008;4(2):96-102.

  4. Springfield SD, Gebhardt CM. Bone and Soft Tissue Tumors. In: Morrissy Raymond T, Weinstein Stuart L, editors. Lovell & Winter's Pediatric Orthopaedics. 6th ed. Baltimore, MD:Lippincott Williams & Wilkins; 2006. p. 494-539.

  5. Arndt CA, Rose PS, Folpe AL, Laack NN. Common Musculoskeletal Tumors of Childhood and Adolescence. Mayo Clin Proc. 2012 May;87(5):475-87.

  6. Villa Muñoz A. Tumores óseos. Rabdomiosarcomas. Pediatr Integral 2012;XVI(7):533-539.

  7. Sánchez-Torres LJ, Santos-Hernández M. El arte de diagnosticar tumores óseos. Acta Ortopédica Mexicana. Ene-Feb 2012;26(1):57-65.

  8. Herring JA. Tumors of the Musculoskeletal System. En: Herring JA, editor. Tachdjian's Pediatric Orthopaedics. 5th ed. Philadelphia: Saunders; 2014. p. 1079-1120.

  9. Kelleher FG, Thomas DM. Molecular pathogenesis and targeted therapeutics in Ewing sarcoma/ primitive neuroectodermaltumours. Clin Sarcoma Research [Internet]. 2012 Feb [citado 2013 May 15];2(1):[about 6 p.]. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3351706/.

  10. Ozaki T. Diagnosis and treatment of Ewing sarcoma of the bone: a review article. J Orthop Sci. 2015;20:250-263.

  11. Lissat A, Chao MM, Konty V. Targeted therapy in Ewing sarcoma. ISRN Oncol [Internet]. 2012 May [citado 2013 May 15];2012(2012):[about 9 p.]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22690342

  12. Berner K, Johannesen TB, Berner A, Haugland HK, Bjerkehagen B, Bøhler P, et al. Time-trends on incidence and survival in a nationwide and unselected cohort of patients with skeletal osteosarcoma. Acta Oncol. 2015;54:25-33.

  13. Aggerholm-Pedersen N, Maretty-Nielsen K, Keller J, Baerentzen S, Schrøder H, Jørgensen PH, et al. The importance of standardized treatment in high-grade osteosarcoma: 30 years of experience from a hospital-based database. Acta Oncol. 2015;54:17-24.

  14. Seker MM, Seker A, Aksoy S, Ozdemir N, Uncu D, Zengin N. Clinicopathologic features and prognosis of osteosarcomain Turkish adults. Asian Pac J Cancer Prev. 2014;15:3537-40.

  15. Janeway J. Nathan and Oski's Hematology and Oncology of Infancy and Childhood. 8tha ed [Internet]. España: Elsevier; 2015 [citado 2017 Apr 12]. Available from: https://www.clinicalkey.es/#!/content/book/3-s2.0-B9781455754144000620

  16. Heck RK, Toy PC. Malignant Tumors of Bone. En: Terry Canale S, editor. Campbell's Operative Orthopaedics [Internet]. España: Elsevier; 2017 [citado 2017 Apr 12]. Available from: https://www.clinicalkey.es/#!/content/book/3-s2.0-B9780323374620000276

  17. Miwa S, Takeuchi A, Ikeda H, Shirai T, Yamamoto N, Nishida H, et al. Prognostic value of histological response to chemotherapy in osteosarcoma patients receiving tumor-bearing frozen autograft. PloS One. 2013;8:e71362.

  18. Lorena Salvo A, Gabriel Cavada Ch. Factores pronósticos de sobrevida de pacientes con osteosarcoma. Rev Chil Ortop Traumatol. 2016;57(1):3-8.

  19. Gabriel Cavada Ch.19 Factores pronósticos de sobrevida de pacientes con osteosarcoma. Rev Chil Ortop Traumatol. 2016;57(1):3-8.

  20. Kelleher FG, Thomas DM. Molecular pathogenesis and targeted therapeutics in Ewing sarcoma/ primitive neuroectodermaltumours. Clin Sarcoma Research [Internet]. 2012 Feb [citado 2013 May 15];2(1):[about 6 p.]. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3351706/.




2020     |     www.medigraphic.com